US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Birth Control

2,812.21

+31.211.12%

Number of Gainers:1

Number of Losers:3

Number of Flat:1

PE:- -

High:2,831.72

Open:2,781.00

Low:2,735.95

Close:2,781.00

Volume:11.10M

Turnover:290.31M

Market Cap:46.95B

Float Cap:43.83B

Loading ...

Femasys announces Minnesota Women’s Care to implement FemVue

Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care

Teva Pharmaceutical Begins Direct Trading of Shares on NYSE

MT Newswires Live

Daré Bioscience Reports Phase 1 Study Shows Topical Sildenafil Cream Cuts Systemic Exposure Versus Oral Dose

Teva Pharmaceutical Announces Major Senior Notes Financing

Daré Bioscience Lowers Stockholder Meeting Quorum Requirement to One-Third Voting Power

MannKind management to meet with Cantor

Daré Bioscience Posts H.C. Wainwright Investor Conference Presentation for On-Demand Viewing

Teva Announces Successful Pricing of $4.9 billion (Equivalent) Senior Notes

Femasys Partners with CapexMD to Offer Financing for FemaSeed Fertility Portfolio

MannKind Partners with Rose Pharma on Inhaled Rapid-Acting GLP-1 Weight-Loss Therapy

MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration Glp-1 for Weight Management

THOMSON REUTERS

MannKind Corporation: Specific Financial Terms of Agreement were not Disclosed

THOMSON REUTERS

MannKind Corporation - Rose Pharma Receives Exclusive Worldwide License for Technosphere Technology

THOMSON REUTERS

MannKind Corporation - to Provide Development and Manufacturing Support Through Phase 1B in Weight Management Study

THOMSON REUTERS

MannKind Corporation - to Receive Equity Interest in Rose Pharma and Potential Royalties on Future Net Sales

THOMSON REUTERS

MannKind Corporation - to Have Representation on Rose Pharma Board of Directors

THOMSON REUTERS

Teva initiated with an Outperform at Leerink

Veru Plans Phase 2 Trial of Oral Sabizabulin in Daraxonrasib-Resistant Metastatic Pancreatic Cancer

Veru - to Advance Oral Sabizabulin for Metastatic Pancreatic Cancer Resistant to Daraxonrasib

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/BK4584/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK4584","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","market":"US","secType":"PLATE","nameCN":"Birth Control","latestPrice":2812.2063,"timestamp":1789502399999,"preClose":2780.9983,"halted":0,"volume":11098420,"delay":0,"changeRate":0.011222,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":31.208008,"latestTime":"09-15 16:00:00 EDT","open":2780.998,"high":2831.7236,"low":2735.947,"amount":290313783.997081,"amplitude":0.03444,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.752711,"peRate":70.919871,"turnoverRate":0.007728,"increases":1,"decrements":3,"flats":1,"marketCap":46946631741,"floatMarketCap":43833253322},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","high":2831.7236,"amplitude":0.03444,"preClose":2780.9983,"low":2735.947,"pbRate":"5.752711","latestPrice":2812.2063,"volume":11098420,"delay":0,"open":2780.998,"prevYearClose":2379.9924,"prevWeekClose":2785.0151,"prevMonthClose":2714.4358,"prevQuarterClose":2562.5076,"fiveDayClose":2767.868,"twentyDayClose":2741.442,"sixtyDayClose":2380.8992,"secType":"PLATE","market":"US","turnoverRate":0.007728,"peRate":70.919871,"marketCap":46946631741,"floatMarketCap":43833253322,"timestamp":1789502399999,"nameCN":"Birth Control"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4584\",,,,undefined,":{"bkCode":"BK4584","up":1,"down":3,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4584\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667630640","title":"Femasys announces Minnesota Women’s Care to implement FemVue","url":"https://stock-news.laohu8.com/highlight/detail?id=2667630640","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667630640?lang=en_us&edition=fundamental","pubTime":"2026-09-15 21:20","pubTimestamp":1789478419,"startTime":"0","endTime":"0","summary":"Femasys (FEMY) announced that Minnesota Women’s Care will implement FemVue for fertility diagnostic evaluation and FemaSeed Complete for in-office ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/femasys-announces-minnesota-womens-care-to-implement-femvue-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/femasys-announces-minnesota-womens-care-to-implement-femvue-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FEMY","BK4539","BK4584","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667864058","title":"Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2667864058","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667864058?lang=en_us&edition=fundamental","pubTime":"2026-09-15 21:00","pubTimestamp":1789477200,"startTime":"0","endTime":"0","summary":"-- Leading multi-site OB/GYN health practice to implement FemVue for fertility diagnostic evaluation and FemaSeed for first-line treatment across all four locations -- ATLANTA, Sept.  15, 2026 (GLOBE ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/15/3362177/0/en/femasys-advances-ob-gyn-expansion-with-adoption-of-femaseed-fertility-portfolio-by-minnesota-women-s-care.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FEMY","BK4082","BK4584","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667693316","title":"Teva Pharmaceutical Begins Direct Trading of Shares on NYSE","url":"https://stock-news.laohu8.com/highlight/detail?id=2667693316","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667693316?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:02","pubTimestamp":1789390972,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries  ordinary shares began trading directly on the New York Stock Exchange, completing its transition from its American depositary shares program, the drugmaker said Monday.The company said the shares will continue to trade under the ticker \"TEVA\" on both the NYSE and Tel Aviv Stock Exchange.Teva said the direct listing is expected to expand investor access and strengthen its position in US capital markets.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4596","BK4588","TEVA","BK4007","BK4559","BK4566","BK4585","LU1983299246.USD","BK4584","LU2324357040.USD","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667664326","title":"Daré Bioscience Reports Phase 1 Study Shows Topical Sildenafil Cream Cuts Systemic Exposure Versus Oral Dose","url":"https://stock-news.laohu8.com/highlight/detail?id=2667664326","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667664326?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:50","pubTimestamp":1789390221,"startTime":"0","endTime":"0","summary":"Daré Bioscience reports Phase 1 study shows topical sildenafil cream cuts systemic exposure versus oral doseDaré Bioscience reported peer-reviewed publication of Phase 1 results for topical Sildenafil","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL761hnD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","LU2210150020.SGD","IE00BGHQF748.EUR","BCDF","IE00B64PRP62.GBP","SG9999014021.USD","SG9999014005.SGD","DARE","IE00BQXX3F31.USD","IE00BN0W2V16.EUR","NDAQ","BK4007","BK4585","BK4112","IE00BN0W2W23.USD","LU0314104364.USD","SG9999014013.SGD","BK4588","SG9999014039.USD","IE00BKPKM429.USD","LU2095319765.USD","IE00BN0W2T93.GBP","BK4584","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","IE00BQXX3C00.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666734574","title":"Teva Pharmaceutical Announces Major Senior Notes Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2666734574","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666734574?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:33","pubTimestamp":1789158804,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical ( ($TEVA) ) has shared an announcement. On September 10, 2026, Teva announced it had successfully priced approximately $4.9 bil...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/teva-pharmaceutical-announces-major-senior-notes-financing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/teva-pharmaceutical-announces-major-senior-notes-financing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4596","BK4557","LU1983299246.USD","TEVA","LU2324357040.USD","BK4559","BK4007","BK4588","BK4584","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666574383","title":"Daré Bioscience Lowers Stockholder Meeting Quorum Requirement to One-Third Voting Power","url":"https://stock-news.laohu8.com/highlight/detail?id=2666574383","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666574383?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:30","pubTimestamp":1789158651,"startTime":"0","endTime":"0","summary":"Daré Bioscience lowers stockholder meeting quorum requirement to one-third voting powerDaré Bioscience cut the stockholder-meeting quorum threshold to at least one-third of voting power from a majorit","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL7Dhh6D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DARE","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666711195","title":"MannKind management to meet with Cantor","url":"https://stock-news.laohu8.com/highlight/detail?id=2666711195","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666711195?lang=en_us&edition=fundamental","pubTime":"2026-09-12 03:55","pubTimestamp":1789156512,"startTime":"0","endTime":"0","summary":"Meeting to be held in Boston on September 17 hosted by Cantor. Published first on TheFly – the ultimate source for real-time, market-moving breakin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mannkind-management-to-meet-with-cantor-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mannkind-management-to-meet-with-cantor-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4584","MNKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666526782","title":"Daré Bioscience Posts H.C. Wainwright Investor Conference Presentation for On-Demand Viewing","url":"https://stock-news.laohu8.com/highlight/detail?id=2666526782","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666526782?lang=en_us&edition=fundamental","pubTime":"2026-09-11 18:55","pubTimestamp":1789124124,"startTime":"0","endTime":"0","summary":"Daré Bioscience posts H.C. Wainwright investor conference presentation for on-demand viewingDaré Bioscience posted an on-demand investor presentation for the H.C. Wainwright 28th Annual Global Investm","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL58yrZW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","LU2210150020.SGD","IE00BGHQF748.EUR","BCDF","IE00B64PRP62.GBP","SG9999014021.USD","SG9999014005.SGD","DARE","IE00BQXX3F31.USD","IE00BN0W2V16.EUR","NDAQ","BK4007","BK4585","BK4112","IE00BN0W2W23.USD","LU0314104364.USD","SG9999014013.SGD","BK4588","SG9999014039.USD","IE00BKPKM429.USD","LU2095319765.USD","IE00BN0W2T93.GBP","BK4584","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","IE00BQXX3C00.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666627275","title":"Teva Announces Successful Pricing of $4.9 billion (Equivalent) Senior Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2666627275","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666627275?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:04","pubTimestamp":1789034640,"startTime":"0","endTime":"0","summary":"TEL AVIV, Israel, Sept.  10, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today that it successfully priced its offering of approximately $4.9 ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/10/3359281/0/en/teva-announces-successful-pricing-of-4-9-billion-equivalent-senior-notes.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU1983299246.USD","BK4584","BK4156","BK4007","BK4596","TEVA","BK4566","BK4585","BK4557","LU2324357040.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666535312","title":"Femasys Partners with CapexMD to Offer Financing for FemaSeed Fertility Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2666535312","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666535312?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:04","pubTimestamp":1788959042,"startTime":"0","endTime":"0","summary":"Femasys partners with CapexMD to offer financing for FemaSeed fertility portfolioFemasys partnered with CapexMD to offer dedicated patient financing for its FemaSeed-led fertility portfolio.Financing ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDLc5TGtl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4584","LU2210150020.SGD","BK4082","NDAQ","SG9999014021.USD","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","IE00BQXX3D17.EUR","SG9999014013.SGD","BK4539","LU0314104364.USD","LU2095319765.USD","IE00BQXX3C00.GBP","BK4585","FEMY","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","SG9999014039.USD","BK4112","BCDF","IE00BKPKM429.USD","BK4588","LU2210149790.SGD","IE00B3QW5Z07.USD","SG9999014005.SGD","IE00BQXX3F31.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584094","title":"MannKind Partners with Rose Pharma on Inhaled Rapid-Acting GLP-1 Weight-Loss Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584094","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584094?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949853,"startTime":"0","endTime":"0","summary":"MannKind partners with Rose Pharma on inhaled rapid-acting GLP-1 weight-loss therapyMannKind entered a worldwide licensing and collaboration agreement with Rose Pharma to develop ROSE-010 Technosphere","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL6Q2z0v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4584","SG9999014013.SGD","IE00BN0W2T93.GBP","SG9999014039.USD","IE00BN0W2W23.USD","IE00BKPKM429.USD","SG9999014021.USD","LU0314104364.USD","SG9999014005.SGD","IE00BQXX3C00.GBP","LU2210149790.SGD","IE00B64PRP62.GBP","BCDF","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","NDAQ","LU2210150020.SGD","IE00B3QW5Z07.USD","LU2095319765.USD","BK4585","IE00BQXX3F31.USD","BK4588","BK4112","IE00BQXX3D17.EUR","MNKD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666858406","title":"MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration Glp-1 for Weight Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2666858406","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666858406?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA7JNY9J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MNKD","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666840665","title":"MannKind Corporation: Specific Financial Terms of Agreement were not Disclosed","url":"https://stock-news.laohu8.com/highlight/detail?id=2666840665","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666840665?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA7JNY9J:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4584","MNKD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584063","title":"MannKind Corporation - Rose Pharma Receives Exclusive Worldwide License for Technosphere Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584063","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584063?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA7JNY9J:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MNKD","BK4584","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584062","title":"MannKind Corporation - to Provide Development and Manufacturing Support Through Phase 1B in Weight Management Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584062","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584062?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA7JNY9J:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MNKD","BK4139","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666258405","title":"MannKind Corporation - to Receive Equity Interest in Rose Pharma and Potential Royalties on Future Net Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2666258405","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666258405?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA7JNY9J:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4584","MNKD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666061584","title":"MannKind Corporation - to Have Representation on Rose Pharma Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666061584","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666061584?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA7JNY9J:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4584","MNKD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584165","title":"Teva initiated with an Outperform at Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584165","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584165?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:11","pubTimestamp":1788948675,"startTime":"0","endTime":"0","summary":"Leerink initiated coverage of Teva (TEVA) with an Outperform rating and $45 price target Published first on TheFly – the ultimate source for real-t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-initiated-with-an-outperform-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-initiated-with-an-outperform-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TEVA","BK4559","BK4584","BK4596","BK4585","BK4588","BK4566","BK4007","LU1983299246.USD","BK4557","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665320219","title":"Veru Plans Phase 2 Trial of Oral Sabizabulin in Daraxonrasib-Resistant Metastatic Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2665320219","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665320219?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:17","pubTimestamp":1788869844,"startTime":"0","endTime":"0","summary":"Veru plans Phase 2 trial of oral sabizabulin in daraxonrasib-resistant metastatic pancreatic cancerVeru will advance oral sabizabulin into a planned Phase 2 trial for metastatic KRAS-driven pancreatic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLlxV4k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4183","LU2095319765.USD","BK4584","SG9999014013.SGD","IE00BQXX3C00.GBP","IE00BN0W2T93.GBP","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","LU2210150020.SGD","LU2210149790.SGD","IE00BN0W2W23.USD","SG9999014021.USD","BK4585","BK4007","VERU","BCDF","NDAQ","BK4557","IE00BKPKM429.USD","IE00BQXX3F31.USD","BK4588","SG9999014005.SGD","IE00B3QW5Z07.USD","LU0314104364.USD","IE00B64PRP62.GBP","SG9999014039.USD","IE00BQXX3D17.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665296320","title":"Veru - to Advance Oral Sabizabulin for Metastatic Pancreatic Cancer Resistant to Daraxonrasib","url":"https://stock-news.laohu8.com/highlight/detail?id=2665296320","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665296320?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:17","pubTimestamp":1788869820,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUAL04RT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4584","BK4557","VERU","BK4183","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":41,"code":"91000000","status":"200"}]}}